Affect Therapeutics — an app that treats users for substance use disorders (SUDs) — has raised $6 million in seed funding, Behavioral Health Business reports. City Light Capital, Kapor Capital, Acumen and AlleyCorp participated in the round. Read more.
Affect Therapeutics Scores $6M in Seed Funding: Report
